Skip to main content
. 2023 Jul 1;24(4):208–213. doi: 10.5152/ThoracResPract.2023.22154

Table 1.

Characteristics of the Population with Asthma

Total
(n = 142)
Vitamin D P
<20 ng/mL
(n = 94)
≥20 ng/mL
(n = 48)
Age (years), mean ± SD 34.6 ± 10.4 36.0 ± 10.2 31.8 ± 10.3 .024
Sex, female, n (%) 106 (74.6) 69 (73.4) 37 (77.1) .634
Current smoking, n (%) 8 (5.6) 6 (6.4) 2 (4.2) .717
Alcohol consumption, n (%) 33 (23.2) 18 (19.1) 15 (31.3) .106
Atopic comorbidity, n (%)
 Allergic rhinitis 117 (82.4) 74 (78.7) 43 (89.6) .108
 Food allergy 27 (19.0) 18 (19.1) 9 (18.8) .954
 Atopic dermatitis 13 (9.2) 8 (8.5) 5 (10.4) .709
 Urticaria 7 (4.9) 2 (2.1) 5 (10.4) .044
BMI (kg/m2), mean ± SD 29.1 ± 6.2 29.8 ± 6.7 27.9 ± 4.9 .078
Hospitalization in the previous year, n (%) 52 (36.6) 32 (34.0) 20 (41.7) .372
ACT, points
 Mean ± SD 15.2 ± 5.4 14.6 ± 5.4 16.2 ± 5.3 .103
 ≥20, n (%) 40 (28.2) 24 (25.5) 16 (33.3) .328
Allergic sensitization, n (%)
 Mites 94 (66.2) 60 (63.8) 34 (70.8) .404
 Cockroaches 70 (49.3) 45 (47.9) 25 (52.1) .635
 Trees 67 (47.2) 43 (45.7) 24 (50.0) .631
 Epithelia 57 (40.1) 37 (39.4) 20 (41.7) .791
 Weeds 60 (42.3) 36 (38.3) 24 (50.0) .182
 Grass 43 (30.3) 29 (30.9) 14 (29.2) .836
 Fungi 18 (12.7) 12 (12.8) 6 (12.5) .964
Respiratory function, mean ± SD
 % predicted baseline
 FVC 87.9 ± 18.3 85.1 ± 18.9 93.4 ± 16.0 .011
 FEV1 71.2 ± 19.2 68.8 ± 20.55 75.9 ± 15.4 .039
 FEV1/FVC 67.1 ± 10.3 66.7 ± 11.2 67.9 ± 8.1 .493
Total serum IgE, IU/mL
 Median (P25-P75) 211 (74-502) 204 (67-524) 224 (82-501) .626
 IgE ≥100, n (%) 95 (66.9) 61 (64.9) 34 (70.8) .477
Vitamin D, ng/mL
 Mean ± SD 18.4 ± 8.1 14.2 ± 3.7 26.5 ± 8.2 <.0001
 ≥20, n (%) 48 (33.8) N/A N/A N/A
Eosinophils, cells/µL
 Mean ± SD 418.1 ± 344.5 464 ± 378 328 ± 247 .025
 Median (P25-P75) 340 (205-580) 359 (227-602) 240 (145-477) .023

ACT, asthma control test; BMI, body mass index; FEV1, forced expiratory volume; FVC, forced vital capacity; IgE, immunoglobulin E; N/A, not applicable; P25-P75, percentile 25-percentile 75.